Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older
ClinicalTrials.gov study NCT01453088. IPD Sharing: Not stated. Countries: 1. Publications: 55.
Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants
ClinicalTrials.gov study NCT00622505. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03567616. IPD Sharing: YES. Countries: 3. Publications: 1.
LCI-HEM-MYE-CRD-002: Carfilzomib-Revlimid-Dexamethasone-Elotuzumab in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03361306. IPD Sharing: NO. Countries: 1. Publications: 1.
Belantamab Mafodotin, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04896658. IPD Sharing: NO. Countries: 1. Publications: 17.
A Study to Determine Dose, Safety, Tolerability, Drug Levels, and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Participants With Multiple Myeloma
ClinicalTrials.gov study NCT02773030. IPD Sharing: Not stated. Countries: 11. Publications: 2.
A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02076009. IPD Sharing: Not stated. Countries: 18. Publications: 8.
Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT00530816. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates
ClinicalTrials.gov study NCT00577642. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Real-World Analysis of Belantamab Mafodotin Care Patterns in Patients With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05986682. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma
ClinicalTrials.gov study NCT01335399. IPD Sharing: Not stated. Countries: 20. Publications: 1.
A Study of Melphalan Flufenamide (Melflufen) Plus Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02963493. IPD Sharing: Not stated. Countries: 4. Publications: 3.
Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT01090921. IPD Sharing: NO. Countries: 1. Publications: 1.
Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT01572480. IPD Sharing: YES. Countries: 1. Publications: 7.
Safety and Tolerability of BION-1301 in Adults With Relapsed or Refractory Multiple Myeloma (MM)
ClinicalTrials.gov study NCT03340883. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)
ClinicalTrials.gov study NCT03173092. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT00103506. IPD Sharing: Not stated. Countries: 17. Publications: 3.
UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy
ClinicalTrials.gov study NCT00083551. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM)
ClinicalTrials.gov study NCT00617591. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study Evaluating The Safety And Pharmacokinetics Of Escalating Doses Of RO7297089 In Patients With Relapsed Or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04434469. IPD Sharing: YES. Countries: 4. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.